SAN DIEGO, Calif., Oct. 2 /PRNewswire/ -- Quidel Corporation
(Nasdaq: QDEL), a leading provider of rapid point-of-care (POC) diagnostic
tests, today announced that its President and Chief Executive Officer,
S. Wayne Kay, and its Vice President and Chief Financial Officer, Paul E.
Landers, will present at the UBS Warburg Global Life Sciences Conference in
New York on October 12, 2001 at 7:20 A.M. Eastern Standard Time.
Individuals interested in listening to the live conference presentation
may do so by calling (800) 500-0177 (domestic), or (719) 457-2679
(international). To listen to the recorded presentation, call (877) 710-5304
(domestic) or (402) 220-0702 (international). The recording will be available
for 30 days following the conclusion of the conference.
Quidel Corporation discovers, develops, manufactures and markets rapid
point-of-care diagnostic tests for detection of medical conditions and
illnesses. These products provide accurate, rapid and cost-effective
diagnostic information for acute and chronic conditions associated with
women's health, in areas such as reproduction and diseases of the elderly.
Quidel also provides point-of-care diagnostics for infectious diseases,
including influenza A and B, strep throat, H. pylori infection, chlamydia,
infectious mononucleosis and bacterial vaginosis. Quidel's products are sold
to healthcare professionals for use in physicians' offices, clinical
laboratories and pharmacies, and to consumers through organizations that
provide private label, store brand products. These tests provide diagnostic
information to enable rapid treatment and improve health outcomes, lower costs
and increase patient satisfaction. For more information, please visit
Quidel's Web site at http://www.quidel.com.
Bruce Voss, email@example.com,
or Martin Halsallmhalsall@lhai.com,
of Lippert/Heilshorn & Associates,+1-310-691-7100;
or Paul E. Landers, Vice President & CFO,+1-858-552-7962,
or Andrea Wasilew, firstname.lastname@example.org, Manager ofInvestor Relations, +1-858-552-7955,
both of Quidel Corporation